Comparative sensitivities between different plasma B-type natriuretic peptide assays in patients with minimally symptomatic heart failure (Q46495189)

22 December 2017

title

Comparative sensitivities between different plasma B-type natriuretic peptide assays in patients with minimally symptomatic heart failure (English)

1 reference

22 December 2017

author name string

W H Wilson Tang

1

1 reference

22 December 2017

Kiran Philip

2

1 reference

22 December 2017

Stanley L Hazen

3

1 reference

22 December 2017

Cindy E Stevenson

4

1 reference

22 December 2017

Michael Pepoy

5

1 reference

22 December 2017

Sarah Neale

6

1 reference

22 December 2017

Gary S Francis

7

1 reference

22 December 2017

Frederick Van Lente

8

1 reference

22 December 2017

Andrew Smith

9

1 reference

22 December 2017

Alan H B Wu

10

1 reference

22 December 2017

publication date

1 January 2005

1 reference

22 December 2017

published in

Clinical cornerstone

1 reference

22 December 2017

volume

7 Suppl 1

1 reference

22 December 2017

page(s)

S18-24

1 reference

22 December 2017

ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Gu

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980010-9

7 January 2021

The epidemiology of "asymptomatic" left ventricular systolic dysfunction: implications for screening

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980010-9

7 January 2021

Prevalence of left-ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening study: a population based study

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980010-9

7 January 2021

Natural history of incidentally discovered, asymptomatic idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980010-9

7 January 2021

Natural history of asymptomatic left ventricular systolic dysfunction in the community

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980010-9

7 January 2021

Reliability of N-terminal proBNP assay in diagnosis of left ventricular systolic dysfunction within representative and high risk populations

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980010-9

7 January 2021

Is B-type natriuretic peptide a useful screening test for systolic or diastolic dysfunction in patients with coronary disease? Data from the Heart and Soul Study

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980010-9

7 January 2021

Biochemical detection of left-ventricular systolic dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980010-9

7 January 2021

Value of plasma B type natriuretic peptide measurement for heart disease screening in a Japanese population

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980010-9

7 January 2021

The limited value of plasma B-type natriuretic peptide for screening for left ventricular hypertrophy among hypertensive patients

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980010-9

7 January 2021

Identification of previously undiagnosed left ventricular systolic dysfunction: community screening using natriuretic peptides and electrocardiography

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980010-9

7 January 2021

Use of NT-proBNP in routine testing and comparison to BNP.

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980010-9

7 January 2021

Screening for cardiac dysfunction in asymptomatic patients by measuring B-type natriuretic peptide levels

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980010-9

7 January 2021

Plasma brain natriuretic peptide to detect preclinical ventricular systolic or diastolic dysfunction: a community-based study

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980010-9

7 January 2021

Plasma B-type natriuretic peptide levels in ambulatory patients with established chronic symptomatic systolic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980010-9

7 January 2021

Analytical and clinical evaluation of the Bayer ADVIA Centaur automated B-type natriuretic peptide assay in patients with heart failure: a multisite study

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980010-9

7 January 2021

Preliminary evaluation of the AxSYM B-type natriuretic peptide (BNP) assay and comparison with the ADVIA Centaur BNP assay

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980010-9

7 January 2021

Biological variation for N-terminal pro- and B-type natriuretic peptides and implications for therapeutic monitoring of patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980010-9

7 January 2021

Natriuretic peptides as markers of mild forms of left ventricular dysfunction: effects of assays on diagnostic performance of markers

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980010-9

7 January 2021

Biochemical diagnosis of impaired left ventricular ejection fraction--comparison of the diagnostic accuracy of brain natriuretic peptide (BNP) and amino terminal proBNP (NT-proBNP).

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980010-9

7 January 2021

Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction: the Framingham heart study

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980010-9

7 January 2021

NT-proBNP and the diagnosis of heart failure: a pooled analysis of three European epidemiological studies

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980010-9

7 January 2021

A prospective study in search of an optimal B-natriuretic peptide level to screen patients for cardiac dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980010-9

7 January 2021

Prognostic role of B-type natriuretic peptide levels in patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980010-9

7 January 2021

Usefulness of B-type natriuretic peptide (BNP) as a screen for left ventricular abnormalities in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980010-9

7 January 2021

Elevated plasma levels of Nt-proBNP in patients with type 2 diabetes without overt cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980010-9

7 January 2021

The effect of diabetes on B-type natriuretic peptide concentrations in patients with acute dyspnea: an analysis from the Breathing Not Properly Multinational Study

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980010-9

7 January 2021

Utility of B-type natriuretic peptide (BNP) as a screen for left ventricular dysfunction in patients with diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980010-9

7 January 2021

Usefulness of B-type natriuretic peptide in elderly patients with acute dyspnea

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980010-9

7 January 2021

Prognostic value of high plasma brain natriuretic peptide concentrations in very elderly persons

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980010-9

7 January 2021

Screening for left ventricular systolic dysfunction among patients with risk factors for heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980010-9

7 January 2021

Cost-effectiveness of screening with B-type natriuretic peptide to identify patients with reduced left ventricular ejection fraction

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980010-9

7 January 2021

Screening for left ventricular dysfunction using a hand-carried cardiac ultrasound device

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980010-9

7 January 2021

10.1016/S1098-3597(05)80010-9

Identifiers

DOI

1 reference

22 December 2017

release_m3rqrb4xivbbzaba4fowltplye

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/m3rqrb4xivbbzaba4fowltplye

24 November 2022

mapped directly with Wikidata item

1 reference

22 December 2017